OHI director granted 3,778 restricted shares

Omega Healthcare Investors director Lisa Egbuonu-Davis received a grant of 3,778 shares of common stock as director compensation on June 5, 2026.

Rhea-AI Filing Summary

Omega Healthcare Investors director Lisa Egbuonu-Davis received a grant of 3,778 shares of common stock as director compensation on June 5, 2026. The award was made via a Restricted Stock Grant Award Agreement at an indicated value of $43.67 per share.

The restricted shares will vest on the date of the company’s 2027 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis. Following this compensation grant, Egbuonu-Davis directly holds 22,432 shares of Omega Healthcare Investors common stock.

Insider Trade Summary

Grant/Award: 3,778 shares

Grant/Award 1 txn

Insider Egbuonu-Davis Lisa

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,778	$43.67	$165K

Holdings After Transaction: Common Stock — 22,432 shares (Direct)

Footnotes (1)

1. F1. Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement which will vest on the date of the Company's 2027 Annual Meeting of Shareholders, which is approximately one (1) year from the date of the grant and will convert to common stock on a one-for-one basis.

Key Figures

Restricted stock grant size: 3,778 shares Grant reference price: $43.67 per share Post-transaction holdings: 22,432 shares +1 more

4 metrics

Restricted stock grant size 3,778 shares Director compensation grant on June 5, 2026

Grant reference price $43.67 per share Indicated value for the June 5, 2026 award

Post-transaction holdings 22,432 shares Total common shares directly held after the grant

Vesting timing 2027 Annual Meeting Restricted stock vests at 2027 shareholder meeting

Key Terms

Restricted Stock Grant Award Agreement, vest, convert to common stock, grant, award, or other acquisition

4 terms

Restricted Stock Grant Award Agreement financial

"Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement"

vest financial

"which will vest on the date of the Company's 2027 Annual Meeting of Shareholders"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

convert to common stock financial

"and will convert to common stock on a one-for-one basis"

grant, award, or other acquisition financial

"transaction code description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OHI director Lisa Egbuonu-Davis report?

Lisa Egbuonu-Davis reported receiving 3,778 shares of Omega Healthcare Investors common stock as director compensation. The grant was made on June 5, 2026 under a Restricted Stock Grant Award Agreement at an indicated value of $43.67 per share.

Is the OHI director’s June 2026 stock grant an open-market purchase?

No, the June 2026 transaction is a compensation-related grant, not an open-market purchase. The Form 4 characterizes it as a grant or award acquisition, reflecting routine director compensation instead of a discretionary buy in the market.

When will Lisa Egbuonu-Davis’s 3,778 OHI restricted shares vest?

The 3,778 restricted shares will vest on the date of Omega Healthcare Investors’ 2027 Annual Meeting of Shareholders. At vesting, they convert to common stock on a one-for-one basis, assuming continued service and satisfaction of any applicable vesting conditions.

How many OHI shares does the director hold after this Form 4 transaction?

After receiving the 3,778-share grant, Lisa Egbuonu-Davis directly holds 22,432 shares of Omega Healthcare Investors common stock. This figure reflects her direct ownership position reported immediately following the June 5, 2026 compensation award transaction.

What does the Form 4 say about the type of OHI shares granted?

The Form 4 indicates the award is in the form of restricted stock that will convert to common stock on a one-for-one basis at vesting. This means each restricted share becomes one share of Omega Healthcare Investors common stock when vesting conditions are met.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/09/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Egbuonu-Davis Lisa

(Last) (First) (Middle)

303 INTERNATIONAL CIRCLE

SUITE 200

(Street)

HUNT VALLEY MARYLAND 21030

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		3,778(1)	A	$43.67	22,432	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement which will vest on the date of the Company's 2027 Annual Meeting of Shareholders, which is approximately one (1) year from the date of the grant and will convert to common stock on a one-for-one basis.

	/s/ Meghan C. Lyons, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)